ID: ALA2058731

Max Phase: Preclinical

Molecular Formula: C16H25NO3

Molecular Weight: 279.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)OCCCCCCCCCOc1ccccn1

Standard InChI:  InChI=1S/C16H25NO3/c1-15(18)19-13-9-5-3-2-4-6-10-14-20-16-11-7-8-12-17-16/h7-8,11-12H,2-6,9-10,13-14H2,1H3

Standard InChI Key:  PEBAMBBDPXZDIB-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania mexicana 936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.38Molecular Weight (Monoisotopic): 279.1834AlogP: 3.75#Rotatable Bonds: 11
Polar Surface Area: 48.42Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.92CX LogP: 3.74CX LogD: 3.74
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.46Np Likeness Score: -0.56

References

1. García Liñares G, Parraud G, Labriola C, Baldessari A..  (2012)  Chemoenzymatic synthesis and biological evaluation of 2- and 3-hydroxypyridine derivatives against Leishmania mexicana.,  20  (15): [PMID:22781310] [10.1016/j.bmc.2012.06.028]

Source